Security key
03152W109
AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD)
CUSIP: 03152W109
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.01 per share
- Total 13F shares
- 797
- Total 13F value
- $11,548
- Share change
- -327,872,152
- SEC-reported price per share
- $14.24
- Number of holders
- 2
- Value change
- -$4,737,467,050
- Number of sells
- 291
- Shares outstanding
- 316,644,581
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
2
Top holders
2
FOLD full security history
Ownership snapshot
Full 13F holder table
AMICUS THERAPEUTICS, INC. SEC filings
AMICUS THERAPEUTICS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2026
13F
13D/G
Lead comparable stake: 7.4%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 7.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
7.4%
UBS Group AG
5.5%
VANGUARD CAPITAL MANAGEMENT LLC
5.2%
Avoro Capital Advisors LLC
4.9%
Redmile Group, LLC
4.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
7.4%
from 13D/G
|
$489,891,036
33,879,048 shares
|
— | 31 Mar 2026 |
| UBS Group AG |
13D/G
13F
Company
|
5.5%
|
$247,870,674
17,141,817 shares
|
$0 | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
5.2%
|
$236,433,103
16,350,837 shares
|
$0 | 31 Mar 2026 |
| Avoro Capital Advisors LLC |
13D/G
|
4.9%
|
$118,397,000
15,025,000 shares
|
-$43,143,000 | 30 Sep 2025 |
| Redmile Group, LLC |
13D/G
|
4.6%
|
$106,667,402
14,184,495 shares
|
$0 | 31 Dec 2024 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13D/G
|
3.4%
|
$151,763,799
10,627,717 shares
|
-$76,348,548 | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
797
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
298
Q2 2026 holders
2
Holder diff
-296
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|